Cargando…

A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A

A simple protocol for generating a highly stable and active surface plasmon resonance (SPR) sensor surface of recombinant human hexahistidine cyclophilin A (His-CypA) is described. The sensor surface was sensitive and stable enough to allow, for the first time, the screening and ranking of several n...

Descripción completa

Detalles Bibliográficos
Autores principales: Wear, Martin A., Patterson, Alan, Malone, Kirk, Dunsmore, Colin, Turner, Nicholas J., Walkinshaw, Malcolm D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094681/
https://www.ncbi.nlm.nih.gov/pubmed/16102717
http://dx.doi.org/10.1016/j.ab.2005.06.037
_version_ 1783510521135235072
author Wear, Martin A.
Patterson, Alan
Malone, Kirk
Dunsmore, Colin
Turner, Nicholas J.
Walkinshaw, Malcolm D.
author_facet Wear, Martin A.
Patterson, Alan
Malone, Kirk
Dunsmore, Colin
Turner, Nicholas J.
Walkinshaw, Malcolm D.
author_sort Wear, Martin A.
collection PubMed
description A simple protocol for generating a highly stable and active surface plasmon resonance (SPR) sensor surface of recombinant human hexahistidine cyclophilin A (His-CypA) is described. The sensor surface was sensitive and stable enough to allow, for the first time, the screening and ranking of several novel small-molecule (M(r) ∼250–500 Da) ligands in a competition binding assay with cyclosporin A (CsA). It also allowed us to accurately determine the kinetic rate constants for the interaction between His-CypA and CsA. His-CypA was first captured on a Ni(2+)–nitrilotriacetic acid (NTA) sensor chip and was then briefly covalently stabilized, coupling via primary amines. The significant baseline drift observed due to dissociation of weakly bound His-CypA from the Ni(2+)–NTA moiety was eliminated, resulting in a surface that was stable for at least 36 h. In addition, immobilized protein activity levels were high, typically between 85 and 95%, assayed by the interaction between His-CypA and CsA. The mean equilibrium dissociation constant for CsA (K(dCsA)) binding to the immobilized His-CypA was 23 ± 6 nM, with on and off rates of 0.53 ± 0.1 μM(−1) s(−1) and 1.2 ± 0.1 (×10(−2)) s(−1), respectively. These values agree well with the values for the corresponding binding constants determined from steady-state and kinetic fluorescence titrations in solution.
format Online
Article
Text
id pubmed-7094681
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-70946812020-03-25 A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A Wear, Martin A. Patterson, Alan Malone, Kirk Dunsmore, Colin Turner, Nicholas J. Walkinshaw, Malcolm D. Anal Biochem Article A simple protocol for generating a highly stable and active surface plasmon resonance (SPR) sensor surface of recombinant human hexahistidine cyclophilin A (His-CypA) is described. The sensor surface was sensitive and stable enough to allow, for the first time, the screening and ranking of several novel small-molecule (M(r) ∼250–500 Da) ligands in a competition binding assay with cyclosporin A (CsA). It also allowed us to accurately determine the kinetic rate constants for the interaction between His-CypA and CsA. His-CypA was first captured on a Ni(2+)–nitrilotriacetic acid (NTA) sensor chip and was then briefly covalently stabilized, coupling via primary amines. The significant baseline drift observed due to dissociation of weakly bound His-CypA from the Ni(2+)–NTA moiety was eliminated, resulting in a surface that was stable for at least 36 h. In addition, immobilized protein activity levels were high, typically between 85 and 95%, assayed by the interaction between His-CypA and CsA. The mean equilibrium dissociation constant for CsA (K(dCsA)) binding to the immobilized His-CypA was 23 ± 6 nM, with on and off rates of 0.53 ± 0.1 μM(−1) s(−1) and 1.2 ± 0.1 (×10(−2)) s(−1), respectively. These values agree well with the values for the corresponding binding constants determined from steady-state and kinetic fluorescence titrations in solution. Elsevier Inc. 2005-10-15 2005-07-12 /pmc/articles/PMC7094681/ /pubmed/16102717 http://dx.doi.org/10.1016/j.ab.2005.06.037 Text en Copyright © 2005 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wear, Martin A.
Patterson, Alan
Malone, Kirk
Dunsmore, Colin
Turner, Nicholas J.
Walkinshaw, Malcolm D.
A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A
title A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A
title_full A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A
title_fullStr A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A
title_full_unstemmed A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A
title_short A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A
title_sort surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin a
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094681/
https://www.ncbi.nlm.nih.gov/pubmed/16102717
http://dx.doi.org/10.1016/j.ab.2005.06.037
work_keys_str_mv AT wearmartina asurfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT pattersonalan asurfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT malonekirk asurfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT dunsmorecolin asurfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT turnernicholasj asurfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT walkinshawmalcolmd asurfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT wearmartina surfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT pattersonalan surfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT malonekirk surfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT dunsmorecolin surfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT turnernicholasj surfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina
AT walkinshawmalcolmd surfaceplasmonresonancebasedassayforsmallmoleculeinhibitorsofhumancyclophilina